Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

News feed

Assets of the Pharmacy Chain 36.6 were seized in a lawsuit for ₽3.7 billion

1/30/26 APTK

Sollers returned the Net Debt/EBITDA threshold to 1x

1/30/26 SVAV

Overnight will no longer deprive you of personal income tax benefits

1/30/26 MOEX

Lenta expands its network of electric charging stations

1/30/26 LENT

Production of Rushydro in 2025 decreased by 1.6%

1/30/26 HYDR

Production of Unipro in 2025 increased by 3%

1/30/26 UPRO

Kazanorgsintez increased production by 10%

1/29/26 KZOS

Nizhnekamskneftekhim increased production by 15%

1/29/26 NKNC

Polyplast-UralSib launches pilot production of solid epoxy resins

1/29/26 -

Sales of the Samolet in 2025 decreased by 6%

1/29/26 SMLT